GURUFOCUS.COM » STOCK LIST » Asia » Hong Kong » HKSE » Lee's Pharmaceutical Holdings Ltd (HKSE:00950) » Definitions » Dividend Payout Ratio
Switch to:

Lee's Pharmaceutical Holdings (HKSE:00950) Dividend Payout Ratio

: 0.17 (As of Sep. 2022)
View and export this data going back to 2002. Start your Free Trial

Lee's Pharmaceutical Holdings's dividend payout ratio for the months ended in Sep. 2022 was 0.17.

The historical rank and industry rank for Lee's Pharmaceutical Holdings's Dividend Payout Ratio or its related term are showing as below:


During the past 13 years, the highest Dividend Payout Ratio of Lee's Pharmaceutical Holdings was 0.48. The lowest was 0.00. And the median was 0.24.


As of today (2023-03-29), the Dividend Yield % of Lee's Pharmaceutical Holdings is 2.83%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Lee's Pharmaceutical Holdings was 3.53%. The lowest was 0.53%. And the median was 1.42%.

Lee's Pharmaceutical Holdings's Dividends per Share for the months ended in Sep. 2022 was HK$0.01.

During the past 12 months, Lee's Pharmaceutical Holdings's average Dividends Per Share Growth Rate was -32.80% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -16.30% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -12.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 6.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Lee's Pharmaceutical Holdings was 36.20% per year. The lowest was -16.80% per year. And the median was 19.30% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Lee's Pharmaceutical Holdings Dividend Payout Ratio Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Dividend Payout Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.15 0.48 0.30 0.02

Lee's Pharmaceutical Holdings Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Dividend Payout Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.25 - - 2.21 0.17

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Lee's Pharmaceutical Holdings Dividend Payout Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Lee's Pharmaceutical Holdings's Dividend Payout Ratio falls in comparison to its industry or sector. The grey bar indicates the Dividend Payout Ratio's extreme value range as defined by GuruFocus.



Lee's Pharmaceutical Holdings Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Lee's Pharmaceutical Holdings's Dividend Payout Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2021 )/ EPS without NRI (A: Dec. 2021 )
=0.061/ 3.374
=0.02

Lee's Pharmaceutical Holdings's Dividend Payout Ratio for the quarter that ended in Sep. 2022 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2022 )/ EPS without NRI (Q: Sep. 2022 )
=0.01/ 0.058
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lee's Pharmaceutical Holdings (HKSE:00950) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Lee's Pharmaceutical Holdings Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lee's Pharmaceutical Holdings (HKSE:00950) Business Description

Lee's Pharmaceutical Holdings logo
Traded in Other Exchanges
Address
Hong Kong Science Park, Shatin, 1/Floor, Building 20E, Phase 3, Hong Kong, HKG
Lee's Pharmaceutical Holdings Ltd is a Cayman Island-based research-driven and market-oriented biopharmaceutical company. It is integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales, and marketing in China with global perspectives. It focuses on cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology and obstetrics. Its portfolio has two categories of Proprietary products and Licensed-in products. Its maximum revenue is generated from China. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase and Eyprotor. Its Licensed-in Products include Carnitene, Ferplex, ALOXI and Centraxal Plus, among others.

Lee's Pharmaceutical Holdings (HKSE:00950) Headlines

No Headlines